Svennilson Peter
Follow13F filer, CIK 1606074, SAN FRANCISCO, CA
Svennilson Peter reported $321,765,000 across 4 holdings for the quarter ended 2019-09-30, in a 13F-HR filed 2019-11-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000903514-19-000008
- Period
- 2019-09-30
- Reported value
- $322M
- Holdings
- 4
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Stakes and trades reported after 2019-09-30
13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.
- SRZN SURROZEN INC: 13D/A 3,813,501 shares, 18.2% of the class, 13D/A filed 2026-11-18, 0001193125-26-467393Timeline
Accepted , ingested - TNYA TENAYA THERAPEUTICS INC: 13D/A 49,313,559 shares, 21.6% of the class, 13D/A filed 2026-11-16, 0001193125-26-463722Timeline
Accepted , ingested
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| CONSTELLATION PHARMACEUTICALadded | +1,331,763 | $8.6M |
| NGM BIOPHARMACEUTICALS INCadded | +472,816 | $6.55M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
None.
Holdings, Q3 2019
Share positions as resolved from 13F-HR 0000903514-19-000008, largest first. % of portfolio is the value over $321,765,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| NGM BIOPHARMACEUTICALS INCNGM BIOPHARMACEUTICALS INC | 16,166,907 | $224M | 69.59% | +472,816 | |||
| CONSTELLATION PHARMACEUTICALCONSTELLATION PHARMACEUTICAL | 6,009,702 | $38.8M | 12.07% | +1,331,763 | |||
| RCUSARCUS BIOSCIENCES INC | 3,540,850 | $32.2M | 10.01% | 0 | Timeline | ||
| GRITSTONE BIO INCGRITSTONE BIO INC | 3,102,934 | $26.8M | 8.33% | 0 |
How Q3 2019 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000903514-19-000008 | base | 2019-11-14 | acceptance time not in the bulk data set |